Clinical association analysis demonstrated that downregulation of CACNA2D3 was positively correlated with lymph node metastasis (P = 0.01) and advanced clinical staging (P = 0.003, Table 1). The gene discussed is CACNA2D3; the disease is metastatic malignant neoplasm in the lymph nodes.